SILO

Silo Pharma (SILO)

Silo Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SILO

<< 이전 1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/01/10	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SILO	Silo Pharma Inc
2024/01/04	22:55	GlobeNewswire Inc.	Silo Pharma Successfully Completes First Phase of Dose-Ranging Study of SPC-15 an Intranasal Treatment for PTSD	NASDAQ:SILO	Silo Pharma Inc
2023/12/28	22:25	GlobeNewswire Inc.	Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia	NASDAQ:SILO	Silo Pharma Inc
2023/12/22	06:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SILO	Silo Pharma Inc
2023/12/21	06:58	Edgar (US Regulatory)	Form 8-K12B - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b)	NASDAQ:SILO	Silo Pharma Inc
2023/12/19	09:44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SILO	Silo Pharma Inc
2023/12/12	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SILO	Silo Pharma Inc
2023/12/08	08:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SILO	Silo Pharma Inc
2023/12/06	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SILO	Silo Pharma Inc
2023/12/05	06:55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SILO	Silo Pharma Inc
2023/12/01	11:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SILO	Silo Pharma Inc
2023/11/28	07:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SILO	Silo Pharma Inc
2023/11/23	06:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SILO	Silo Pharma Inc
2023/11/21	22:01	GlobeNewswire Inc.	Silo Pharma Enters into Exclusive License Agreement with Medspray Pharma BV for Intranasal Technology used in SPC-15 Treatment for PTSD	NASDAQ:SILO	Silo Pharma Inc
2023/11/21	09:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SILO	Silo Pharma Inc
2023/11/14	07:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SILO	Silo Pharma Inc
2023/11/08	22:11	GlobeNewswire Inc.	Silo Pharma to Initiate Dose-Ranging Study of Novel Intranasal Therapeutic SPC-15 for the Treatment of PTSD	NASDAQ:SILO	Silo Pharma Inc
2023/10/24	06:01	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:SILO	Silo Pharma Inc
2023/10/24	06:00	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SILO	Silo Pharma Inc
2023/10/16	21:11	GlobeNewswire Inc.	Silo Pharma’s SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis	NASDAQ:SILO	Silo Pharma Inc
2023/10/11	21:35	GlobeNewswire Inc.	Silo Pharma Initiates Human Factor Study of SPC-15 for the Treatment of PTSD	NASDAQ:SILO	Silo Pharma Inc
2023/10/11	05:00	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:SILO	Silo Pharma Inc
2023/09/20	21:28	GlobeNewswire Inc.	Silo Pharma Announces Positive Data on SPC-15 for PTSD and Prepares to File Pre-Investigational New Drug (IND) Application with FDA	NASDAQ:SILO	Silo Pharma Inc
2023/09/12	21:50	GlobeNewswire Inc.	Silo Pharma Initiates Feasibility Study of SPC-15 Novel Intranasal Formulation for PTSD	NASDAQ:SILO	Silo Pharma Inc
2023/08/31	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SILO	Silo Pharma Inc
2023/08/12	05:50	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SILO	Silo Pharma Inc
2023/08/10	21:50	GlobeNewswire Inc.	Silo Pharma Engages Clarivate for Intellectual Property and Patent Management	NASDAQ:SILO	Silo Pharma Inc
2023/08/08	21:30	GlobeNewswire Inc.	Silo Pharma Reaches Positive Milestone with Nasal Formulation of SPC-15 For Anxiety, PTSD, and Stress-Related Disorders	NASDAQ:SILO	Silo Pharma Inc
2023/06/30	05:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SILO	Silo Pharma Inc
2023/06/30	05:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SILO	Silo Pharma Inc